PAR 2.00% 24.5¢ paradigm biopharmaceuticals limited..

Community Adoption / Mr Federer, page-41

  1. 1,686 Posts.
    lightbulb Created with Sketch. 3114
    1% chance of approval because the drug is repurposed...?

    If PPS is not approved, it will not be down to effectiveness or safety. The trials are a formality as we already have a tremendous amount of real world data and knowledge. It all depends on what big pharma's agenda is.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.005(2.00%)
Mkt cap ! $85.70M
Open High Low Value Volume
25.0¢ 25.5¢ 24.0¢ $187.1K 755.0K

Buyers (Bids)

No. Vol. Price($)
2 47906 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 13363 1
View Market Depth
Last trade - 16.10pm 11/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.